Abstract
High density lipoproteins have a well-established, negative correlation with risk of cardiovascular disease. There is currently particular interest in trying to exploit this relationship by raising serum high density lipoprotein cholesterol to lower risk. More recent studies suggest that high density lipoproteins have a more widespread impact on cardiovascular pathophysiology, beyond its involvement in cholesterol metabolism. The lipoprotein influences the functioning of endothelial cells and cardiomyocytes in a manner suggesting a protective effect under conditions of physiological stress. On-going studies are investigating the magnitude of the influence of the lipoprotein on cell function, notably be defining the signalling pathways that are involved. Advances in this area will be discussed in the following review. These studies may identify new avenues that can be explored as potential targets to treat cardiovascular disease. A logical extension is to consider the high density lipoprotein complex itself as a potential therapeutic. In this respect the ability to synthesise artificial high density lipoproteins with functional properties of the native lipoprotein complex is a particularly attractive option. Such studies have already been initiated, as will be discussed below.
Current Signal Transduction Therapy
Title:Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins
Volume: 7 Issue: 2
Author(s): Richard W. James, Miguel A. Frias and Sandrine Lecour
Affiliation:
Abstract: High density lipoproteins have a well-established, negative correlation with risk of cardiovascular disease. There is currently particular interest in trying to exploit this relationship by raising serum high density lipoprotein cholesterol to lower risk. More recent studies suggest that high density lipoproteins have a more widespread impact on cardiovascular pathophysiology, beyond its involvement in cholesterol metabolism. The lipoprotein influences the functioning of endothelial cells and cardiomyocytes in a manner suggesting a protective effect under conditions of physiological stress. On-going studies are investigating the magnitude of the influence of the lipoprotein on cell function, notably be defining the signalling pathways that are involved. Advances in this area will be discussed in the following review. These studies may identify new avenues that can be explored as potential targets to treat cardiovascular disease. A logical extension is to consider the high density lipoprotein complex itself as a potential therapeutic. In this respect the ability to synthesise artificial high density lipoproteins with functional properties of the native lipoprotein complex is a particularly attractive option. Such studies have already been initiated, as will be discussed below.
Export Options
About this article
Cite this article as:
W. James Richard, A. Frias Miguel and Lecour Sandrine, Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins, Current Signal Transduction Therapy 2012; 7 (2) . https://dx.doi.org/10.2174/157436212800376627
DOI https://dx.doi.org/10.2174/157436212800376627 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Effects Elicited In Vitro by Red Wine on Human Healthy Peripheral Blood Mononuclear Cells: Potential Therapeutical Application of Polyphenols to Diet-Related Chronic Diseases
Current Pharmaceutical Design Development of Nitric Oxide Donors for the Treatment of Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?
Current Signal Transduction Therapy A Case-Control Study Investigating the Effect of MTHFR C677T Variant on Performance of Elite Athletes
Endocrine, Metabolic & Immune Disorders - Drug Targets Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a New Biomarker for Non – Acute Kidney Injury (AKI) Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
Current Cancer Drug Targets Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Effect of Long Chain n-3 PUFA on Endothelial Activation, Endothelial Function and Atheromatous Plaque Stability
Current Nutrition & Food Science Natural Products to Anti-trypanosomal Drugs: An Overview of New Drug Prototypes for American Trypanosomiasis
Cardiovascular & Hematological Agents in Medicinal Chemistry Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Current Pharmaceutical Design Coronary Artery Disease and End-Stage Renal Disease - A Clinical Perspective
Current Hypertension Reviews Getting Patients to Target- Implementing the Guidelines
Current Vascular Pharmacology Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature
Current Cardiology Reviews Nocturnal Hypertension, Nondipping Phenomenon and Target Organ Damage in Obstructive Sleep Apnea Patients - The Bad and the Worse
Current Respiratory Medicine Reviews Bioactive Proteins and Peptides from Soybeans
Recent Patents on Food, Nutrition & Agriculture Physical Activity and Diabetic Cardiomyopathy: Myocardial Adaptation Depending on Exercise Load
Current Diabetes Reviews Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation
Current Drug Targets Nothing But Stress – The Interplay of Angiotensin II, Inflammation, Hypertension and Atherosclerosis: Implications for Atherosclerotic Plaque Stability
Vascular Disease Prevention (Discontinued) Gene Electrotransfer to Skin; Review of Existing Literature and Clinical Perspectives
Current Gene Therapy